Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 33

1.

Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial.

Montorsi F, Nathan HP, McCullough A, Brock GB, Broderick G, Ahuja S, Whitaker S, Hoover A, Novack D, Murphy A, Varanese L.

J Urol. 2004 Sep;172(3):1036-41. Erratum in: J Urol. 2005 Feb;173(2):664.

PMID:
15311032
2.

[Treatment of erectile dysfunction after radical retropubic prostatectomy with PDE5 inhibitor].

Jin W, Huang YR.

Zhonghua Nan Ke Xue. 2005 Sep;11(9):708-12. Review. Chinese.

PMID:
16209216
3.

Tadalafil.

Curran M, Keating G.

Drugs. 2003;63(20):2203-12; discussion 2213-4. Review. Erratum in: Drugs. 2003;63(23):2703.

PMID:
14498756
4.

Spotlight on vardenafil in erectile dysfunction.

Keating GM, Scott LJ.

Drugs Aging. 2004;21(2):135-40. Review.

PMID:
14960129
5.

Erection hardness: a unifying factor for defining response in the treatment of erectile dysfunction.

Mulhall JP, Levine LA, J√ľnemann KP.

Urology. 2006 Sep;68(3 Suppl):17-25. Review.

PMID:
17011372
6.

Vardenafil.

Ormrod D, Easthope SE, Figgitt DP.

Drugs Aging. 2002;19(3):217-27; discussion 228-9. Review. Erratum in: Drugs Aging 2002;19(11):886. Drugs Aging. 2003;20(2):140..

PMID:
12027779
7.

Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option.

Donatucci CF, Wong DG, Giuliano F, Glina S, Dowsett SA, Watts S, Sorsaburu S.

Curr Med Res Opin. 2008 Dec;24(12):3383-92. doi: 10.1185/03007990802498440 . Review. Erratum in: Curr Med Res Opin. 2009 Feb;25(2):505. Curr Med Res Opin. 2010 Mar;26(3):632.

PMID:
19032120
8.

Stopwatch-assessed duration of erection: a new measure of the efficacy of erectile dysfunction treatments.

Rosenberg MT, Miner MM, Barnes AL, Janning SW.

Int J Impot Res. 2011 Jan-Feb;23(1):9-16. doi: 10.1038/ijir.2010.30. Epub 2010 Dec 23. Review.

PMID:
21179109
9.
10.

Efficacy and safety of phosphodiesterase type 5 (PDE5) inhibitors in treating erectile dysfunction after bilateral nerve-sparing radical prostatectomy.

Cui Y, Liu X, Shi L, Gao Z.

Andrologia. 2016 Feb;48(1):20-8. doi: 10.1111/and.12405. Epub 2015 Feb 15. Review.

PMID:
25684196
11.

Cardiovascular effects of tadalafil.

Kloner RA, Mitchell M, Emmick JT.

Am J Cardiol. 2003 Nov 6;92(9A):37M-46M. Review.

PMID:
14609622
12.

IC351 (tadalafil, Cialis): update on clinical experience.

Porst H.

Int J Impot Res. 2002 Feb;14 Suppl 1:S57-64. Review.

13.

Oral phentolamine: an alpha-1, alpha-2 adrenergic antagonist for the treatment of erectile dysfunction.

Goldstein I.

Int J Impot Res. 2000 Mar;12 Suppl 1:S75-80. Review.

PMID:
10845768
14.

Avanafil: a review of its use in patients with erectile dysfunction.

Sanford M.

Drugs Aging. 2013 Oct;30(10):853-62. doi: 10.1007/s40266-013-0112-x. Review.

PMID:
23955441
15.
16.

[Tadalafil rehabilitation therapy for erectile dysfunction following prostatectomy].

Fan Y.

Zhonghua Nan Ke Xue. 2012 Oct;18(10):953-6. Review. Chinese.

PMID:
23297507
17.

Cardiovascular effects of tadalafil in patients on common antihypertensive therapies.

Kloner RA, Mitchell M, Emmick JT.

Am J Cardiol. 2003 Nov 6;92(9A):47M-57M. Review.

PMID:
14609623
18.

Systematic review and meta-analysis of the use of phosphodiesterase type 5 inhibitors for treatment of erectile dysfunction following bilateral nerve-sparing radical prostatectomy.

Wang X, Wang X, Liu T, He Q, Wang Y, Zhang X.

PLoS One. 2014 Mar 11;9(3):e91327. doi: 10.1371/journal.pone.0091327. eCollection 2014. Review.

19.

Correlations with satisfaction measures in men treated with phosphodiesterase inhibitors for erectile dysfunction.

Mulhall JP, Kaminetsky JC, Althof SE, Goldstein I, Creanga DL, Marfatia A, Symonds T, Budhwani M.

Am J Mens Health. 2011 May;5(3):261-71. doi: 10.1177/1557988310389165. Epub 2011 Mar 15. Review.

PMID:
21406491
20.

Current and future strategies for preventing and managing erectile dysfunction following radical prostatectomy.

Montorsi F, Briganti A, Salonia A, Rigatti P, Burnett AL.

Eur Urol. 2004 Feb;45(2):123-33. Review.

PMID:
14733995

Supplemental Content

Support Center